bioRxivMicrobiologyPreprint
2,4-Diacetylphloroglucinol Against Candida albicans: Biofilm Formation, Aspartyl Protease Production and Ultrastructure Changes
Abstract
The dimorphic fungus Candida albicans is the one of the most important opportunistic pathogen of human. The use of fungicides against candida encounters sub-inhibitory effects, which are fungal stress response and undesirable for the host. In this work we investigated antifungal action of 2,4-diacetylphloroglucinol against Candida albicans ATCC 10231 with focus on they biofilm forming ability under the treatment. It was found that 2,4-DAPG reduced ability of candida cells to form biofilm, but complete inhibition or irradiation did not achieve. Moreover, Candida albicans cells in the adherent state have been characterized by reduced susceptibility to 2,4-DAPG comparing to planktonic cells. Investigation of mechanisms which could be explain the antibiofilm action of 2,4-DAPG has revealed the reduction in cells surface hydrophobicity and inhibition of yeast-to-hyphae transition. Biofilms formed under the sub-inhibitory concentrations of 2,4-DAPG were depleted in protein and carbohydrate content. Furthermore, we microscopically visualized the treated biofilms and have revealed numerous cannels localized on hyphae and associated with secretion of aspartyl proteases (Sap). We assumed what excretion of Sap is triggered by reactive oxygen generated upon affecting of mitochondrion respiration by 2,4-DAPG. Introducing of antioxidant Trolox simultaneously with 2,4-DAPG lead to reducing of Sap production. Thus, production of aspartyl proteases is a one of undesirable side effect of Candida albicans treatment, but using 2,4-DAPG in combination with antioxidants is the solution to overcome it.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combination of antifungal drugs and protease inhibitors prevent Candida albicans biofilm formation and disrupt mature biofilms
M. B. Lohse, M. Gulati, … C. J. Nobile·bioRxiv·Feb 11, 2020
- Antifungal effects of alantolactone on Candida albicans: an in vitro study
- Curcumin-Sophorolipid nano-conjugate inhibits Candida albicans filamentation and biofilm development
V. Rajasekar, P. Darne, … P. Neelakantan·bioRxiv·Aug 12, 2020
- Aqueous Spice Extracts as Alternative Antimycotics to Control Highly Drug Resistant Extensive Biofilm Forming Clinical Isolates of Candida albicans
B. Sadanandan, V. Vijayalakshmi, … R. Awaknavar·bioRxiv·Jan 17, 2023
- CO2 enhances the ability of Candida albicans to form biofilms, overcome nutritional immunity and resist antifungal treatment
D. R. Pentland, F. A. Muhlschlegel, C. W. Gourlay·bioRxiv·Mar 31, 2020
- Alexidine dihydrochloride has broad spectrum activities against diverse fungal pathogens
Z. Mamouei, A. Alqarihi, … P. Uppuluri·bioRxiv·Oct 3, 2018